Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma.

CONCLUSION: There was significant correlation between CD44(+)/CD24(-/low) tumor cell prevalence and tumor metastasis, prognosis and chemotherapy response. The CD44(+)/CD24(-) phenotype may be an important factor for malignant relapse following surgical resection and chemotherapy in patients with invasive ductal carcinoma. PMID: 26617852 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/26617852?dopt=Abstract

Source: Clinical Breast Cancer - December 2, 2015 Category: Cancer & Oncology Authors: Chen Y, Song J, Jiang Y, Yu C, Ma Z Tags: Int J Clin Exp Pathol Source Type: research